No Data
Probo Medical Names Michael Asmer as Chairman and Greg Kopulos as CEO
Avista Analyst Ratings
UBS Initiates Avista(AVA.US) With Sell Rating, Announces Target Price $37
UBS analyst Ross Fowler initiates coverage on $Avista(AVA.US)$ with a sell rating, and sets the target price at $37.According to TipRanks data, the analyst has a success rate of 55.1% and a total
Express News | Avista Corp : BofA Global Research Reinstates Coverage With Underperform Rating; Price Objective $37
A Look At The Intrinsic Value Of Avista Corporation (NYSE:AVA)
Express News | Avista Utilities: Request for Proposal Responses Are Due by Oct 29